FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to novel thermodynamically stable modification of (±)-1-(4-carbazolyl-oxy)-3-[2-(2-methoxyphenoxy)ethylamino] -2- propanol (carvedilol) with melting point 123-126 C. X-ray diffraction pattern of this modification obtained by using radioactive source CuKα, angle 2θ exhibits the following values: 9.5; 10.8; 12.0; 14.5; 19.6; 21.5 and 22.3 and its infra- red spectrum shows acute peak at 3451 cm-1. Method of synthesis of and isolation of carvedilol involves rearrangement of crude carvedilol in methanol at temperature 25-35 C for 3-22 h and obtained modification is isolated from reactive mixture slowly cooled to temperature 0 C. Pharmaceutical composition designated for therapy of cardiovascular diseases involves practically pure form of stable modification of (±)-1-(4- carbazolyloxy)-3-[2-(2-methoxyphenoxy)-ethylamino]-2-propanol as acting substance in combination with one or some pharmaceutically acceptable carriers or adjuvants. EFFECT: improved method of synthesis and preparing, valuable medicinal properties. 6 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PSEUDOPOLYMORPHOUS FORMS OF CARVEDIOL | 2002 |
|
RU2308449C2 |
CARVEDILOL HYDROPHILIC MOLECULAR DISPERSED SOLUTION | 2001 |
|
RU2248204C2 |
COMBINED PHARMACEUTICAL ERYTHROPOIETIN- AND IRON-CONTAINING PREPARATIONS | 1997 |
|
RU2188033C2 |
NEW CRYSTALLINE MODIFICATION 2-(3, 5-BIS-TRIFLUOROMETHYLPHENYL)-H-[6-(1, 1-DIOXO-1 λ -THIOMORPHOLINE-4-YL)-4-(4-FLUORO-2-MEHTYLPHENYL)PIRIDINE-3-YL]-K-METHYLISOBUTYR AMIDE | 2004 |
|
RU2330022C2 |
METHOD FOR PREPARING PHARMACEUTICAL PRODUCT CARVEDILOL AND INTERMEDIATE COMPOUND | 1998 |
|
RU2216539C2 |
CRYSTALLINE POLYMORPHYL OF 4-[5-(PYRIDINE-4-YL)-1H-1,2,4-TRIAZOL-3-YL]-PYRIDINE-2-CARBONITRILE AND METHOD OF ITS OBTAINING | 2013 |
|
RU2639149C2 |
IMPROVED METHOD OF SYNTHESIS OF THIAZOLIDINEDIONES, NEW THIAZOLIDINEDIONES AND MEDICINAL AGENTS BASED ON THEREOF | 1998 |
|
RU2181724C2 |
METHOD FOR PREPARING PHARMACEUTICAL PRODUCT | 1998 |
|
RU2245875C2 |
4-HETEROCYCLYLSULFONEAMIDYL-6-METHOXY-5-(2-METHOXYPHENOXY)-2-PYRIDYLPYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2201928C1 |
CRYSTALLINE FUMARATE SALT OF (S)-[3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)PHENYL][3-HYDROXY-3-(PIPERIDINE-2-YL)AZETIDINE-1-YL]METHANONE | 2016 |
|
RU2762181C2 |
Authors
Dates
2003-04-20—Published
1998-07-18—Filed